Novo Nordisk's new chief executive, Mike Doustdar, has told the JPM Healthcare conference that the key to competing in the GLP-1 agonist category for weight loss will be to make the most of cash-pay ...

Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

Nvidia eyes first breakout of 2026. These clues — and an innovative deal with Eli Lilly — bode well.

Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli ...

Illumina on Tuesday unveiled what it calls the world’s largest functional cell dictionary that, when paired with artificial ...

Eli Lilly partnership a "monumental effort" to speed up drug creation, despite Wall Street ignoring major AI shift.

“The dynamics of the policy changes that have occurred in the last year-plus since the Trump administration are certainly ...

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

The Gulf Specimen Marine Lab will have to take down its sign and is urging for an ordinance change to help them put up a new ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

The FDA has instructed Novo Nordisk and Eli Lilly to remove suicide risk warnings from their weight-loss medications after a ...